References
- Thomas D. M., ü’Sullivan B., Gronchi A. Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management. Expert Rev Anticancer Ther [Review], 2009, 9: 1145–1157.
- Pisters P. W. Retroperitoneal sarcomas--an SOS to colleagues in Europe. Ann Surg Oncol [Comment Editorial], 2007, 14: 17871789.
- Bossi A., De Wever I., Van Limbergen E., Vanstraelen B. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys [Evaluation Studies], 2007, 67: 164–170.
- Pepe M. S., Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data ? Stat Med [Research Support, U.S. Gov’t, PH.S.], 1993, 12: 737–751.
- Fine J. P., Gray K. J. A proportional hazards model for the subdistribution of a competing risk. JASA, 1999, 94: 496–509.
- Heinze G., Gnant M., Schemper M. Exact log-rank tests for unequal follow-up. Biometrics, 2003, 59: 1151–1157.
- Schemper M., Smith T. I. A note on quantifying follow-up in studies of failure time. Control Clin Trials, 1996, 17: 343–346.
- Tzeng C. W., Fiveash J. B., Popple K. A., Arnoletti J. P., Russo S. M., Urist M. M. et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperito-neal sarcoma. Cancer [Clinical Trial], 2006, 107: 371–379.
- Koshy M., Landry J. C., Lawson J. D., Staley C. A., Esiashvili N., Howell R., et al. Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction. Sarcoma, 2003, 7: 137–148.
- White J. S., Biberdorf D., DiFrancesco I. M., Kurien E., Temple W. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann Surg Oncol, 2007, 14: 583–590.
- Jones J. J., catton c. N., o’Sullivan B., couture J., Heisler R. I., Kandel R. A. et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retro-peritoneal sarcoma. Ann Surg Oncol [Clinical Trial], 2002, 9: 346–354.
- Singer S., Antonescu c. R., Riedel E., Brennan M. F. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg, 2003, 238: 358–70; discussion 70–71.
- Brennan M. F. Retroperitoneal sarcoma: time for a national trial ? Ann Surg Oncol [Comment Editorial], 2002, 9: 324–325.